All pharmaceutical companies operating in the EAEU market (Kazakhstan, Belarus, Russia, Armenia, Kyrgyzstan) have to obtain the EAEU GMP certificate. 

The process of EAEU GMP inspection is a challenge for many international pharmaceutical companies. That is why it is highly recommended to be prepared for inspection in advance and to conduct pre-audit of the respective manufacturing site. This will identify the possible gaps regarding the EAEU GMP guidelines before the official inspection. 

Inpharmatis has over 15 years of experience in conducting GMP pre-audits and successfully supporting global and local pharmaceutical companies with official GMP inspections. Additionally, Inpharmatis has full competence in supporting EAEU regulatory procedures. 

Inpharmatis covers all EAEU countries with full-time, highly qualified, multilingual employees who operate under a global quality system. 

For more information, please contact us at info@inpharmatis.com.